Fluindione and drug reaction with eosinophilia and systemic symptoms: An unrecognised adverse effect?

European Journal of Clinical Pharmacology

Volumn 68, Issue 1, 2012, Pages 101-105

  Daveluy, Amélie ^a,b,c   Milpied, Brigitte ^c   Barbaud, Annick ^d   Lebrun Vignes, Bénédicte ^e   Gouraud, Aurore ^f   Laroche, Marie Laure ^g   Ciobanu, Ecaterina ^h   Bégaud, Bernard ^a,b,c   Moore, Nicholas ^a,b,c   Miremont Salamé, Ghada ^a,b,c   Haramburu, Françoise ^a,b,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d SERVICE DE DERMATOLOGIE   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f HOSPICES CIVILS DE LYON   (France)

^g LIMOGES UNIVERSITY HOSPITAL   (France)

^h UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Anticoagulants; Drug hypersensitivity; Drug reaction with eosinophilia and systemic symptoms; Fluindione

Indexed keywords

AMIODARONE; BISOPROLOL; CARBAMAZEPINE; CEFIXIME; CEFUROXIME; CODEINE; COTRIMOXAZOLE; COUMARIN DERIVATIVE; DICLOFENAC; DIGOXIN; DOXYCYCLINE; FLUINDIONE; OFLOXACIN; RIFAMPICIN; SPIRAMYCIN; SPIRONOLACTONE; VANCOMYCIN;

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRESS SYNDROME; DRUG CONTRAINDICATION; DRUG SURVEILLANCE PROGRAM; FEMALE; FEVER; FRANCE; HEPATITIS; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY; LIVER; LYMPHADENOPATHY; MALE; ORGANS AT RISK; PATCH TEST; PRIORITY JOURNAL; RASH; SCHOOL CHILD;

ADMINISTRATION, ORAL; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EOSINOPHILIA; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PHARMACOVIGILANCE; PHENINDIONE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SKIN TESTS; VITAMIN K;

EID: 84857065256     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1101-9     Document Type: Article

References (25)

1. Assurance maladie (2009) Médicaments remboursés par le Régime général au cours des années 2004 à 2008. http://www.ameli.fr/fileadmin/user-upload/documents/MedicAM-2004-2008- ameli.zip. Accessed 18 January 2011
2. Ministère de la santé: Commission nationale de pharmacovigilance (1987) Enquête sur les hépatites à la fluindione
3. P Tubert B Bégaud F Haramburu JC Péré 1991 Spontaneous reporting: how many cases are required to trigger a warning? Br J Clin Pharmacol 32 407 408 1958431 1:STN:280:DyaK38%2FmvVKqsw%3D%3D
4. M Biour JM Davy T Poynard VG Lévy 1990 La fluindione est-elle hépatotoxique? Gastroenterol Clin Biol 14 782 2262128 1:STN:280:DyaK3M%2FosFOksQ%3D%3D
5. JF Cadranel R Demontis M Seddik S Ramdani D Belloula M Biour 2008 Toxicité hépatique et rénale de la fluindione (Previscan®) Gastroenterol Clin Biol 32 816 818 18818035 10.1016/j.gcb.2008.07.003
6. F Grunenberger L Thiry N Sader JL Schlienger M Imler 1995 Fièvre prolongée induite par la fluindione Rev Med Interne 16 973 974 8570965 10.1016/0248-8663(96)80823-X 1:STN:280:DyaK287ksFOjug%3D%3D (Pubitemid 26024101)
7. B Gilson JP Aymard P Trechot P Bindi P Netter G Gay 1991 Thrombocytopénie et néphropathie tubulo-interstitielle associées à la prise de fluindione Therapie 46 390 391 1754986 1:STN:280:DyaK38%2FpsVGguw%3D%3D
8. S Belmouaz E Desport R Abou Ayache A Thierry A Mignot M Bauwens JM Goujon F Bridoux G Touchard 2006 Acute immuno-allergic interstitial nephritis caused by fluindione Clin Nephrol 66 455 458 17176918 1:STN:280:DC%2BD28jjvFSnuw%3D%3D (Pubitemid 44896155)
9. A Sparsa C Bédane H Benazahary P De Vencay ML Gauthier V Le Brun S Boulinguez V Loustaud-Ratti P Soria E Vidal JM Bonnetblanc 2001 Syndrome d'hypersensibilité médicamenteuse à la fluindione Ann Dermatol Venereol 128 1014 1018 11907960 1:STN:280:DC%2BD387nsFagtw%3D%3D
10. EG Brown 2002 Effects of coding dictionary on signal generation: a consideration of use of MedDRA compared with WHO-ART Drug Saf 25 445 452 12071782 10.2165/00002018-200225060-00009 (Pubitemid 34729144)
11. SH Kardaun A Sidoroff L Valeyrie-Allanore S Halevy BB Davidovici M Mockenhaupt JC Roujeau 2007 Variability in the clinical pattern of cutaneous side effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 156 609 611 17300272 10.1111/j.1365-2133.2006.07704.x 1:STN:280:DC%2BD2s7gtFCrsA%3D%3D
12. P Cacoub P Musette V Descamps O Meyer C Speirs L Finzi JC Roujeau 2011 The DRESS syndrome: a literature review Am J Med 124 588 597 21592453 10.1016/j.amjmed.2011.01.017 1:CAS:528:DC%2BC3MXnslSiu7w%3D
13. A Perrin-Lamarre N Petitpain P Trechot J Cuny J Schmutz A Barbaud 2010 Toxidermies aux glycopeptides: résultats des explorations immunoallergologiques dans une série de huit cas Ann Dermatol Venereol 137 101 105 20171430 10.1016/j.annder.2010.01.005 1:STN:280: DC%2BC3c7pslKqsQ%3D%3D
14. B Bégaud JC Evreux J Jouglard G Lagier 1985 Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France Therapie 40 111 118 4002188
15. JC Roujeau 2005 Clinical heterogeneity of drug hypersensitivity Toxicology 210 123 133 10.1016/j.tox.2004.12.022 (Pubitemid 40568639)
16. T Shiohara M Inaoka Y Kano 2006 Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpes viruses and antiviral and antidrug immune responses Allergol Int 55 1 8 17075280 10.2332/allergolint.55.1
17. T Shiohara M Iijima Z Ikezawa K Hashimoto 2007 The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivation Br J Dermatol 156 1045 1092 10.1111/j.1365-2133. 2007.07807.x (Pubitemid 46642847)
18. H Bocquet M Bagot JC Roujeau 1996 Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS) Semin Cutan Med Surg 15 250 257 9069593 10.1016/S1085-5629(96)80038-1 1:STN:280:DyaK2s3it1Gltg%3D%3D (Pubitemid 27197964)
19. E Frouin B Roth A Grange F Grange MC Tortel JC Guillaume 2005 Syndrome d'hypersensibilité à la fluindione (Previscan®). Positivité des tests épicutanés Ann Dermatol Venereol 132 1000 1002 16446646 10.1016/S0151-9638(05)79566-1 1:STN:280: DC%2BD28%2FmtlSmtA%3D%3D (Pubitemid 43182457)
20. RD deShazo SF Kemp 1997 Allergic reactions to drugs and biologic agents JAMA 278 1895 1906 9396651 10.1001/jama.1997.03550220101014 1:STN:280: DyaK1c%2Flslemug%3D%3D (Pubitemid 28007263)
21. JS Wright 1970 Phenindione sensitivity with leukaemoid reaction and hepato-renal damage Postgrad Med J 46 452 455 4248923 10.1136/pgmj.46.537.452 1:STN:280:DyaE3M%2FisFyiuw%3D%3D
22. Sweetman SC (2009) Martindale. The complete drug reference, 36th edn. Pharmaceutical Press, London
23. N Pereira de Silva P Piquioni S Kochen P Saidon 2011 Risk factors associated with DRESS syndrome produced by aromatic and non-aromatic anti-epileptic drugs Eur J Clin Pharmacol 67 463 470 21359537 10.1007/s00228-011-1005-8 1:CAS:528:DC%2BC3MXkvVWns70%3D
24. L Hazell SAW Shakir 2006 Under-reporting of adverse drug reactions: a systematic review Drug Saf 29 385 396 16689555 10.2165/00002018-200629050-00003
25. Y Moride F Haramburu AA Requejo B Bégaud 1997 Under-reporting of adverse drug reactions in general practice Br J Clin Pharmacol 43 177 181 9131950 10.1046/j.1365-2125.1997.05417.x 1:STN:280:DyaK2s3islSqsg%3D%3D (Pubitemid 27085369)